Reveal HealthTech, a startup with operations in India and the US, has announced its $7.2 million Series A round led by Leo Capital with participation from Sanos Capital.
Founded in 2023 and incubated by W Health Ventures and 2070 Health, Reveal has quickly built a reputation as the “healthcare AI specialist” at the intersection of cutting-edge artificial intelligence (AI) and deep healthcare expertise.
AI in healthcare is no longer an experiment at the fringes, but is redefining how patients are diagnosed, how treatments are delivered, and how healthcare companies operate. In this landscape, Reveal HealthTech is positioned as a catalyst driving AI adoption through its world-class team that brings the best of academic excellence (from MIT, Harvard Medical, UC Berkeley amongst others) and decades of technology innovation experience (from Boston Children’s, Mass Gen, SpaceX, NASA, Athena Health, Infosys and many others).
Reveal’s solutions focus on driving customer value and improving profitability of healthcare operations. Its flagship offerings include BioCanvas® which enables multimodal AI use cases such as speeding up clinical trial recruitment using AI, and Prism AI® for rapid development of intelligent agents for workflow automation. In a recent deployment for a $40 billion US medical device leader, Reveal helped improve patient adherence through AI-driven data integration and creating a re-usable blueprint for other clients.
The Series A funding will help Reveal expand its capabilities and solutions, strengthen its sales network, and extend its reach to more healthcare and life sciences leaders worldwide. As part of this commitment, Reveal HealthTech has joined the Cipher Collective, an ECG-powered AI partner network, bringing together best-in-class health technology solutions to transform care delivery.
